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Independent predictors p value OR 95% CI for OR
High bifurcation angle () <0.0001 1.026 1.014-1.037
Plaque distribution at
the same side of SB
0.0045 1.988 1.237-3.194
MV TIMI ﬂow grade before stenting <0.0001 4.204 2.099-8.420
Pre-procedural diameter stenosis
of bifurcation core (%)
0.0037 1.013 1.004-1.021
Diameter ratio between
MV/SB
<0.0001 5.901 2.933-11.872
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An Angiographic Tool For Risk Prediction Of Side Branch Occlusion In
Coronary Bifurcation Intervention: The RESOLVE Score System
Kefei Dou1, Dong Zhang1, Bo Xu1, Dong Yin1
1Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing,
China
Background: The risk of side branch (SB) occlusion is the most important consid-
eration affecting the selection of an optimal intervention strategy in patients under-
going coronary bifurcation intervention. We aim to establish a scoring system to
evaluate the risk of SB occlusion.
Methods: 1545 consecutive patients undergoing percutaneous coronary inter-
vention for bifurcation lesions (1601 lesions treated with a single stent
technique or main vessel (MV) stenting ﬁrst strategy) were studied. 1200
lesions were used for the construction of the risk model and score system, 401
lesions were used for validating the model. A multivariable risk score was
constructed with incremental weights attributed to each component variable
according to their estimated coefﬁcients. SB occlusion after MV stenting was
deﬁned as any decrease in TIMI ﬂow grade or absence of ﬂow in SB after
MV stenting.
Results: SB occlusion occurred in 118 (7.37%) of 1601 bifurcation lesions. In
multivariable analyses, 6 variables (Table 1) were independently associated with
the risk of SB occlusion (model C-statistic¼0.80 (95% conﬁdence interval [CI]:
0.75 to 0.85) with good calibration). Lesions divided into groups according to the
quartile of RESOLVE score: quartile I was determined as low risk group (score:
0-2); quartiles II and III were combined into an intermediate risk group (score: 3-
9); and quartile IV described high risk group (score: 10). For the 401 lesions
included in the validation cohort, the RESOLVE score had a C-statistic¼0.77
(95% CI: 0.69 to 0.86), with good calibration. SB occlusion rates in the vali-
dation cohort increased signiﬁcantly across different risk groups from 0.0% in
low risk group to 3.8% in intermediate risk group, to 19.8% in high risk group
(p< 0.001).
Conclusions: The RESOLVE score, a novel angiographic risk stratiﬁcation
tool, can help identify patients at risk for SB occlusion during bifurcation
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How Bifurcation Angle Impact The Fate Of Side Branch After Main Vessel
Stenting: Results From A Large Center
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College, Beijing, China, 2Fu Wai Hospital, National Center for Cardiovascular
Diseases, China, Beijing, China
Background: Bifurcation angle (BA) was thought to impact the risk of side branch
(SB) occlusion in coronary bifurcation patients undergoing percutaneous coronary
intervention (PCI). We aim to investigate the effect of BA on SB occlusion after main
vessel (MV) stenting.
Methods: 1171 consecutive patients undergoing PCI for bifurcation lesions (1200
lesions treated with a single stent technique or MV stenting ﬁrst strategy) were
studied. Lesions were divided into low angle and high angle groups using the median
BA (52): 600 lesions in low angle group (52) and 600 lesions in high angle group
(>52). Clinical characteristics, coronary angiography ﬁndings, PCI procedural fac-
tors and quantitative coronary angiographic analysis data were collected. Multivariate
logistic regression analysis was performed to identify independent predictors of SB
occlusion.
Results: SB occlusion occurred in 88 (7.33%) of 1200 bifurcation lesions treated with
one stent technique or MV stenting ﬁrst strategy. Rate of SB occlusion was signiﬁ-
cantly higher in high angle group (67, 10.1%) than low angle group (21, 3.9%) (p<
0.001). Rate of SB occlusion increased signiﬁcantly across different quartiles of BA:
from 3.63% in the ﬁrst quartile of BA, to 4.71% in quartile II, to 8.14% in quartile III
to 12.97% in quartile IV. Multivariable analysis showed that high angle was an in-
dependent predictor of SB occlusion (OR: 1.026, 95% conﬁdence intervals [CI]:
1.014-1.037). 5 other angiographic and procedural factors were also signiﬁcant and
independent predictors of SB branch occlusion (Table 1).
Conclusions: High BA was signiﬁcantly associated with SB occlusion after MV
stenting. Plaque distribution at the same side of SB, MV TIMI ﬂow grade before
stenting, pre-procedural diameter stenosis of bifurcation core, diameter ratio between
MV/SB and diameter stenosis of SB before MV stenting were also independent
predictors of SB occlusion.Diameter stenosis of SB
before MV stenting (%)
<0.0001 1.029 1.018-1.040TCT-181
A Comparative Prospective Analysis of Drug Eluting Stent with Biodegradable
Polymer versus Drug Eluting Stent with Permanent Polymer in Bifurcation
Lesions
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Background: Clinical outcomes of percutaneous coronary intervention (PCI) in
coronary bifurcation lesions are in general inferior compared to non-bifurcation le-
sions even when treated using drug eluting stents (DES). Our aim was to compare
performance of new Ultimaster DES with bioresorbable polymer with Xience DES
with permanent polymer, in this complex clinical setting.
Methods: In the frame of a large (1123 patients), randomized, intercontinental
CENTURY II study, 194 patients (269 lesions) had at least one bifurcation lesion
treated and randomly assigned to either Ultimaster (95) or Xience DES (99). The study
had 100% on-site monitoring and all events were adjudicated by an independent
clinical event committee.
Results: There were no signiﬁcant differences in demographic characteristics,
approximately 28% of the patients were female, 30% of the patients had diabetes
mellitus, 73% hypertension and 32% had previous MI. Most of the patients were
admitted with stable angina (50%). Patients treated with Ultimaster DES had signif-
icantly more multivessel disease and consequently multivessel treatment: 57.9% vs.
34.7%; (p¼0.04); and 43.4% vs. 20.2% (p¼0.02), respectively. Most of the bifur-
cation lesions were classiﬁed as 1.1.0 (29%), followed by 1.1.1 (22%) and 0.1.1 (10%)
according to “Medina” and most frequent vessel treated was left anterior descending
(48%), with no signiﬁcant differences between the study arms. The number of stent
implanted and the total stent length per patient were signiﬁcantly higher in Ultimasterronary Lesions - Bifurcations B53
